Suppr超能文献

高密度脂蛋白(HDL)在巨噬细胞中的抗炎作用优于动脉粥样硬化斑块中的促炎作用。

Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques.

机构信息

From the Division of Molecular Medicine, Department of Medicine, Columbia University, New York (P.F., D.G.T., M.W., M.M.M., E.A., S.A., N.W., A.R.T.).

Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, UW Medicine Diabetes Institute, University of Washington, Seattle (V.K., Y.H., J.W.H., K.E.B.).

出版信息

Arterioscler Thromb Vasc Biol. 2019 Dec;39(12):e253-e272. doi: 10.1161/ATVBAHA.119.313253. Epub 2019 Oct 3.

Abstract

OBJECTIVE

HDL (high-density lipoprotein) infusion reduces atherosclerosis in animal models and is being evaluated as a treatment in humans. Studies have shown either anti- or proinflammatory effects of HDL in macrophages, and there is no consensus on the underlying mechanisms. Here, we interrogate the effects of HDL on inflammatory gene expression in macrophages. Approach and Results: We cultured bone marrow-derived macrophages, treated them with reconstituted HDL or HDL isolated from mice, and challenged them with lipopolysaccharide. Transcriptional profiling showed that HDL exerts a broad anti-inflammatory effect on lipopolysaccharide-induced genes and proinflammatory effect in a subset of genes enriched for chemokines. Cholesterol removal by POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) liposomes or β-methylcyclodextrin mimicked both pro- and anti-inflammatory effects of HDL, whereas cholesterol loading by POPC/cholesterol-liposomes or acetylated LDL (low-density lipoprotein) before HDL attenuated these effects, indicating that these responses are mediated by cholesterol efflux. While early anti-inflammatory effects reflect reduced TLR (Toll-like receptor) 4 levels, late anti-inflammatory effects are due to reduced IFN (interferon) receptor signaling. Proinflammatory effects occur late and represent a modified endoplasmic reticulum stress response, mediated by IRE1a (inositol-requiring enzyme 1a)/ASK1 (apoptosis signal-regulating kinase 1)/p38 MAPK (p38 mitogen-activated protein kinase) signaling, that occurs under conditions of extreme cholesterol depletion. To investigate the effects of HDL on inflammatory gene expression in myeloid cells in atherosclerotic lesions, we injected reconstituted HDL into or mice fed a Western-type diet. Reconstituted HDL infusions produced anti-inflammatory effects in lesion macrophages without any evidence of proinflammatory effects.

CONCLUSIONS

Reconstituted HDL infusions in hypercholesterolemic atherosclerotic mice produced anti-inflammatory effects in lesion macrophages suggesting a beneficial therapeutic effect of HDL in vivo.

摘要

目的

高密度脂蛋白(HDL)输注可减少动物模型中的动脉粥样硬化,并正在被评估作为人类的一种治疗方法。研究表明,HDL 在巨噬细胞中具有抗炎或促炎作用,但其潜在机制尚无定论。在这里,我们研究了 HDL 对巨噬细胞中炎症基因表达的影响。

方法和结果

我们培养了骨髓来源的巨噬细胞,用重组 HDL 或从 小鼠中分离的 HDL 处理它们,并用脂多糖对它们进行刺激。转录谱分析显示,HDL 对脂多糖诱导的基因具有广泛的抗炎作用,并对一组富含趋化因子的基因具有促炎作用。POPC(1-棕榈酰-2-油酰基-甘油-3-磷酸胆碱)脂质体去除胆固醇或β-甲基环糊精模拟了 HDL 的促炎和抗炎作用,而 POPC/胆固醇脂质体或乙酰化 LDL(低密度脂蛋白)预处理 HDL 则减弱了这些作用,表明这些反应是由胆固醇流出介导的。虽然早期的抗炎作用反映了 TLR(Toll 样受体)4 水平的降低,但晚期的抗炎作用是由于 IFN(干扰素)受体信号的降低。促炎作用发生较晚,代表一种经过修饰的内质网应激反应,由 IRE1a(肌醇需要酶 1a)/ASK1(凋亡信号调节激酶 1)/p38 MAPK(p38 丝裂原活化蛋白激酶)信号介导,发生在极端胆固醇耗竭的情况下。为了研究 HDL 对动脉粥样硬化病变中髓样细胞炎症基因表达的影响,我们将重组 HDL 注入喂食西式饮食的 或 小鼠体内。HDL 再注射在动脉粥样硬化病变的巨噬细胞中产生了抗炎作用,而没有任何促炎作用的证据。

结论

在高胆固醇血症的动脉粥样硬化小鼠中,HDL 再注射产生了病变巨噬细胞的抗炎作用,这表明 HDL 在体内具有有益的治疗作用。

相似文献

1
Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques.
Arterioscler Thromb Vasc Biol. 2019 Dec;39(12):e253-e272. doi: 10.1161/ATVBAHA.119.313253. Epub 2019 Oct 3.
2
Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1152-63. doi: 10.1161/ATVBAHA.115.306991. Epub 2016 Apr 14.
3
Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis.
J Am Heart Assoc. 2019 Apr 2;8(7):e010860. doi: 10.1161/JAHA.118.010860.
6
Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1122-31. doi: 10.1161/ATVBAHA.116.307580. Epub 2016 Apr 21.
7
Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
Free Radic Biol Med. 2012 Dec 15;53(12):2256-62. doi: 10.1016/j.freeradbiomed.2012.10.001. Epub 2012 Oct 7.
8
Transgenic CGI-58 expression in macrophages alleviates the atherosclerotic lesion development in ApoE knockout mice.
Biochim Biophys Acta. 2014 Dec;1841(12):1683-90. doi: 10.1016/j.bbalip.2014.08.014.
10

引用本文的文献

3
From Nutrition to Innovation: Biomedical Applications of Egg Components.
Molecules. 2025 Aug 4;30(15):3260. doi: 10.3390/molecules30153260.
4
High-density lipoproteins, Part 1. Epidemiology, antiatherogenic effects, and therapies designed to increase their serum levels.
Am J Prev Cardiol. 2025 Jul 21;23:101068. doi: 10.1016/j.ajpc.2025.101068. eCollection 2025 Sep.
9
10
Exploring the Roles of Liver X Receptors in Lipid Metabolism and Immunity in Atherosclerosis.
Biomolecules. 2025 Apr 14;15(4):579. doi: 10.3390/biom15040579.

本文引用的文献

1
Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque.
Arterioscler Thromb Vasc Biol. 2019 Jan;39(1):89-96. doi: 10.1161/ATVBAHA.118.311366.
5
Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Circulation. 2018 Aug 28;138(9):898-912. doi: 10.1161/CIRCULATIONAHA.117.032636.
6
CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients.
Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):953-963. doi: 10.1161/ATVBAHA.118.310538. Epub 2018 Feb 8.
7
Trials and Tribulations of CETP Inhibitors.
Circ Res. 2018 Jan 5;122(1):106-112. doi: 10.1161/CIRCRESAHA.117.311978. Epub 2017 Oct 10.
8
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial.
Hepatology. 2018 Feb;67(2):549-559. doi: 10.1002/hep.29514. Epub 2017 Dec 26.
9
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
10
Time to ditch HDL-C as a measure of HDL function?
Curr Opin Lipidol. 2017 Oct;28(5):414-418. doi: 10.1097/MOL.0000000000000446.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验